REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 151 filers reported holding REVOLUTION MEDICINES INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $45,140 | -99.9% | 1,895,066 | -5.0% | 3.02% | +9.9% |
| Q3 2022 | $39,343,000 | +1.2% | 1,995,066 | 0.0% | 2.75% | -6.5% |
| Q2 2022 | $38,884,000 | -23.6% | 1,995,066 | 0.0% | 2.94% | -24.8% |
| Q1 2022 | $50,894,000 | -16.9% | 1,995,066 | -18.0% | 3.91% | +7.3% |
| Q4 2021 | $61,210,000 | -29.2% | 2,431,852 | -22.7% | 3.64% | +3.6% |
| Q3 2021 | $86,511,000 | -18.3% | 3,144,700 | -5.8% | 3.52% | -2.3% |
| Q2 2021 | $105,953,000 | -8.5% | 3,338,166 | +32.2% | 3.60% | +39.4% |
| Q1 2021 | $115,847,000 | +17.3% | 2,525,000 | +1.2% | 2.58% | +9.8% |
| Q4 2020 | $98,780,000 | +7.5% | 2,495,066 | -5.5% | 2.35% | -33.5% |
| Q3 2020 | $91,878,000 | +11.0% | 2,640,177 | +0.1% | 3.53% | +11.9% |
| Q2 2020 | $82,737,000 | +36.5% | 2,636,661 | -4.7% | 3.16% | +12.1% |
| Q1 2020 | $60,627,000 | – | 2,767,078 | – | 2.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $139,040,000 | 34.79% |
| Ponoi II Management, LLC | 685,011 | $17,242,000 | 31.32% |
| Nextech Invest Ltd. | 2,968,214 | $74,710,000 | 19.68% |
| Ponoi Management, LLC | 685,011 | $17,242,000 | 15.90% |
| Column Group LLC | 3,347,245 | $84,250,000 | 11.46% |
| TRV GP IV, LLC | 1,419,900 | $35,739,000 | 10.28% |
| Cormorant Asset Management, LP | 2,431,852 | $61,210,000 | 3.64% |
| Boxer Capital, LLC | 3,484,264 | $87,699,000 | 3.41% |
| Casdin Capital, LLC | 2,370,000 | $59,653,000 | 1.68% |
| BVF INC/IL | 1,810,549 | $45,572,000 | 1.65% |